Cannapharmarx Stock Number Of Shares Shorted
| CPMD Stock | USD 0 0.0006 18.75% |
Fundamental analysis of CannaPharmaRx allows traders to better anticipate movements in CannaPharmaRx's stock price by examining its financial health and performance throughout various phases of its business cycle.
CannaPharmaRx |
CannaPharmaRx Company Number Of Shares Shorted Analysis
CannaPharmaRx's Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
More About Number Of Shares Shorted | All Equity Analysis
Shares Shorted | = | Shorted by Public | + | by Institutions |
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
| Competition |
Based on the recorded statements, CannaPharmaRx has 0.0 of outstending shares currently sold short by investors. This is 100.0% lower than that of the Pharmaceuticals sector and about the same as Health Care (which currently averages 0.0) industry. The number of shares shorted for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Crypto Correlations Now
Crypto CorrelationsUse cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |
| All Next | Launch Module |
CannaPharmaRx Fundamentals
| Return On Equity | -2.51 | |||
| Return On Asset | -0.26 | |||
| Current Valuation | 20.13 M | |||
| Shares Outstanding | 257.57 M | |||
| Shares Owned By Insiders | 1.12 % | |||
| Price To Book | 11.05 X | |||
| EBITDA | (6.07 M) | |||
| Net Income | (8.83 M) | |||
| Cash And Equivalents | 5.18 K | |||
| Total Debt | 14.96 M | |||
| Debt To Equity | 7.05 % | |||
| Book Value Per Share | (0.07) X | |||
| Cash Flow From Operations | (2.41 M) | |||
| Earnings Per Share | (0.12) X | |||
| Beta | 0.21 | |||
| Market Capitalization | 2.83 M | |||
| Total Asset | 114.33 K | |||
| Retained Earnings | (28.64 M) | |||
| Working Capital | (285 K) | |||
| Current Asset | 233 K | |||
| Current Liabilities | 518 K | |||
| Net Asset | 114.33 K |
About CannaPharmaRx Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CannaPharmaRx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CannaPharmaRx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CannaPharmaRx based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in CannaPharmaRx Pink Sheet
CannaPharmaRx financial ratios help investors to determine whether CannaPharmaRx Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CannaPharmaRx with respect to the benefits of owning CannaPharmaRx security.